Tag:
spinal muscular atrophy
Latest Headlines
Latest Headlines
NINDS is close to launching its first NeuroNEXT neurobiomarkers study
The National Institute for Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is getting ready to launch the first of the studies through NeuroNEXT, the
Biogen Idec strikes $299M deal for Isis antisense drug
Joining a race of pharma giants to treat rare cases of spinal muscular atrophy, Biogen Idec ( $BIIB ) has committed up to $299 million to grab rights to an antisense drug program in the pipeline at
Biomarker study to aid clinical trial of spinal muscular atrophy drug
In companion research to go along with the first-ever clinical trial of a drug to treat spinal muscular atrophy, the Jasper Clinic in Kalamazoo, MI, is recruiting patients for a clinical study that
